FDA PCAC reviews 7 peptides in July. Read →

PeptideXpo

ACE-031 (ActRIIB-Fc Fusion)

ActRIIB-Fc decoy receptor fusion protein · myostatin pathway

≥ 99.0%CAS (fusion protein — no single CAS; confirm via COA)Custom Blends & OEM

Overview

ACE-031 is a soluble Activin receptor type IIB-Fc (ActRIIB-Fc) fusion protein studied as a myostatin / activin pathway decoy in muscle-mass and metabolic research.

Specifications

CAS
(fusion protein — no single CAS; confirm via COA)
Purity (HPLC)
≥ 99.0%
Common vial sizes
1 mg
MOQ
On request
Lead time
21–45 days
Storage
-20°C, protect from light

Documentation available on request

  • Certificate of Analysis (COA)
  • HPLC Chromatogram
  • Mass-spec spectrum
  • Stability data
  • SDS / MSDS
  • Sequence verification

Regulatory note

Recombinant fusion protein; no single registered CAS. Confirm expression system, glycosylation profile, and identity per batch COA.